0000899243-23-011217.txt : 20230412
0000899243-23-011217.hdr.sgml : 20230412
20230412195045
ACCESSION NUMBER: 0000899243-23-011217
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230410
FILED AS OF DATE: 20230412
DATE AS OF CHANGE: 20230412
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SIMPSON TODD E
CENTRAL INDEX KEY: 0001216477
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-32405
FILM NUMBER: 23816811
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seagen Inc.
CENTRAL INDEX KEY: 0001060736
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911874389
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4255274000
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
STREET 2: SUITE
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA
DATE OF NAME CHANGE: 20001116
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-10
0
0001060736
Seagen Inc.
SGEN
0001216477
SIMPSON TODD E
21823 30TH DRIVE SE
BOTHELL
WA
98021
0
1
0
0
Chief Financial Officer
1
Common Stock
2023-04-10
4
M
0
14980
46.37
A
133926
D
Common Stock
2023-04-10
4
S
0
14980
204.14
D
118946
D
Common Stock
2023-04-10
4
M
0
40364
46.37
A
159310
D
Common Stock
2023-04-10
4
S
0
40364
204.74
D
118946
D
Non-Qualified Stock Option (right to buy)
46.37
2023-04-10
4
M
0
14980
0.00
D
2027-08-17
Common Stock
14980
40364
D
Non-Qualified Stock Option (right to buy)
46.37
2023-04-10
4
M
0
40364
0.00
D
2027-08-17
Common Stock
40364
0
D
Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
The sales reported in this Form 4 were effected pursuant to a written plan adopted on December 9, 2022 that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Reflects sales of common stock executed in multiple transactions at prices ranging from $203.49 to $204.48. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of common stock executed in multiple transactions at prices ranging from $204.49 to $205.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Options vested 25% on 8/17/18 and monthly thereafter until all the options were fully vested on 8/17/21.
By: /s/ Jennifer Prosba For: Todd E. Simpson
2023-04-12